drugset / Trial / NCT05594316
New Treatment of Alopecia Areata
NaSingle-groupOpen-labelTreatment
Summary
Abstract: Alopecia areata is believed to be an autoimmune disease resulting from a breach in the immune privilege of the hair follicles causing non scarring hair loss. Methods: our study included 40 patients from may 2019 to july 2022 diagnosed clinically, dermatoscopically and pathologically as alopecia areata Data were enrolled from department of dermatology and venereology, Al-Hussein hospital.
Timeline
- Start
- 2019-05-01
- Primary completion
- 2022-08-01
- Completion
- 2022-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trichloroacetic acid | Small molecule | 35 % | — |